Functional assessment of potential splice site variants in arrhythmogenic right ventricular dysplasia/cardiomyopathy

Judith A Groeneweg1, Amber Ummels2, Marcel Mulder2

  • 1Department of Cardiology, University Medical Center Utrecht and ICIN-Netherlands Heart Institute, Utrecht, The Netherlands.

Heart Rhythm
|August 5, 2014
PubMed

Insights

Functional analysis of splice site variants in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) genes identified six pathogenic mutations. This research clarifies genetic variants, improving ARVD/C diagnosis and patient care.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetic Disease Mechanisms

Background:

  • Interpreting genetic screening results for arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is challenging.
  • Software algorithms predict variant pathogenicity, but functional assessment provides definitive evidence.
  • This study focuses on variants of uncertain clinical significance in ARVD/C.

Purpose of the Study:

  • To conduct functional analysis of potential splice site variants in patients diagnosed with or suspected of having ARVD/C.
  • To determine the impact of specific genetic variants on RNA splicing.
  • To clarify the pathogenicity of uncertain variants in ARVD/C.

Main Methods:

  • Analyzed nine potential splice site variants in desmosomal genes (PKP2, JUP, DSG2, DSC2) from ARVD/C patients.
  • RNA was isolated from blood samples and analyzed using reverse transcriptase polymerase chain reaction (RT-PCR).
  • Assessed the effect of variants on mRNA splicing, including exon skipping and altered splice site usage.

Main Results:

  • Software predicted splicing effects for all nine variants.
  • Functional analysis confirmed deleterious splicing effects in six of the nine variants.
  • Five intronic variants severely impaired splicing, while only one of four exonic variants showed a significant effect.

Conclusions:

  • Six variants in PKP2, JUP, and DSG2 genes demonstrated a pathogenic effect on mRNA splicing, confirming them as ARVD/C-related mutations.
  • Functional assessment is crucial for accurately interpreting potential splice site variants.
  • These findings enhance patient care and facilitate cascade screening for ARVD/C.
Abstract

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
934
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
427
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
811
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
785
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
20.4K